TRHC — Tabula Rasa HealthCare Share Price
0.000.00%
Last trade - 00:00- $284.07m
- $542.57m
- $299.52m
- 28
- 62
- 98
- 67
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 50.44 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.84 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -21.42% | ||
| Return on Equity | n/a | ||
| Operating Margin | -16.61% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 204.27 | 284.71 | 221.39 | 259.88 | 299.52 | 362.2 | 416.43 | 17.54% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Tabula Rasa HealthCare, Inc. is a healthcare technology company. The Company operates through two segments: CareVention HealthCare and MedWise HealthCare. The CareVention HealthCare segment provides its clients, primarily organizations with programs of All-Inclusive Care for the Elderly (PACE), with medication fulfillment services, cloud-based software, pharmacy benefit management (PBM) solutions, and clinical pharmacist services at the point-of-care. PACE is a Centers for Medicare & Medicaid Services (CMS) sponsored program. The MedWise HealthCare segment provides technology-enabled solutions to promote medication safety and adherence to improve patient outcomes and reduce healthcare costs. The technology-enabled solutions revenue model is primarily based on payments on a PMPM basis, payments on a subscription basis, and payments on a fee-for-service basis for each medication safety review and clinical assessment completed.
Directors
- Calvin Knowlton CHM (71)
- Orsula Knowlton CPR (53)
- Brian Adams CPR (40)
- Michael Greenhalgh CFD (59)
- Celynda Tadlock EVP
- Steve Lemak SVP
- Bob Sullivan CTO
- Jeffrey Difrancesco OTH
- A. Gordon Tunstall LED (77)
- Samira Beckwith IND (68)
- Jan Berger IND (63)
- Dennis Helling IND (72)
- Kathrine O'Brien IND (58)
- Michael Purcell IND (64)
- Pamela Schweitzer IND (62)
- Last Annual
- December 31st, 2022
- Last Interim
- June 30th, 2023
- Incorporated
- May 21st, 2014
- Public Since
- September 29th, 2016
- No. of Shareholders
- 76
- No. of Employees
- 1,027
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- NASDAQ Global Market
- Shares in Issue
- 27,054,536
- Address
- 228 Strawbridge Drive, MOORESTOWN, 08057
- Web
- https://www.tabularasahealthcare.com/
- Phone
- Contact
- Frank Sparacino
- Auditors
- KPMG LLP
Upcoming Events for TRHC
Similar to TRHC
908 Devices.
NASDAQ Global Market
Alpha Teknova
NASDAQ Global Market
AtriCure
NASDAQ Global Market
Brainsway
NASDAQ Global Market
Castle Biosciences
NASDAQ Global Market
FAQ
What is the Tabula Rasa HealthCare share price?
As of Today at 18:21 UTC, shares in Tabula Rasa HealthCare are trading at $10.50. This share price information is delayed by 15 minutes.
How has the Tabula Rasa HealthCare share price performed this year?
Shares in Tabula Rasa HealthCare last closed at $10.50 and the price had moved by +186.1% over the past 365 days. In terms of relative price strength the Tabula Rasa HealthCare share price has outperformed the S&P500 Index by +147.52% over the past year.
What are the analyst and broker recommendations for Tabula Rasa HealthCare?
The overall consensus recommendation for Tabula Rasa HealthCare is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the Tabula Rasa HealthCare dividend yield?
Tabula Rasa HealthCare does not currently pay a dividend.
Does Tabula Rasa HealthCare pay a dividend?
Tabula Rasa HealthCare does not currently pay a dividend.
When does Tabula Rasa HealthCare next pay dividends?
Tabula Rasa HealthCare does not currently pay a dividend.
How do I buy Tabula Rasa HealthCare shares?
To buy shares in Tabula Rasa HealthCare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Tabula Rasa HealthCare?
As of the previous close price of $10.50, shares in Tabula Rasa HealthCare had a market capitalisation of $284.07m.
Where are Tabula Rasa HealthCare shares listed?
Here are the trading details for Tabula Rasa HealthCare:
- Country of listing: United States
- Exchange: NMQ
- Ticker Symbol: TRHC
What kind of share is Tabula Rasa HealthCare?
Based on an overall assessment of its quality, value and momentum Tabula Rasa HealthCare is currently classified as a Turnaround. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Tabula Rasa HealthCare share price forecast for 2023?
We could not find analyst target price data for this security.
What is the trend in the Tabula Rasa HealthCare share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Tabula Rasa HealthCare. Over the past six months, its share price has outperformed the S&P500 Index by +86.34%.
As of the last closing price of $10.50, shares in Tabula Rasa HealthCare were trading +38.24% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Tabula Rasa HealthCare PE Ratio?
The Tabula Rasa HealthCare PE ratio based on its reported earnings over the past 12 months is 50.44. The shares last closed at $10.50.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Tabula Rasa HealthCare?
Tabula Rasa HealthCare's management team is headed by:
- Calvin Knowlton - CHM
- Orsula Knowlton - CPR
- Brian Adams - CPR
- Michael Greenhalgh - CFD
- Celynda Tadlock - EVP
- Steve Lemak - SVP
- Bob Sullivan - CTO
- Jeffrey Difrancesco - OTH
- A. Gordon Tunstall - LED
- Samira Beckwith - IND
- Jan Berger - IND
- Dennis Helling - IND
- Kathrine O'Brien - IND
- Michael Purcell - IND
- Pamela Schweitzer - IND